Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication July 8, 2020
- Accepted for publication September 16, 2020
- Published online June 1, 2021.
Article Versions
- previous version (January 28, 2021 - 06:23).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Hui K. Gan1–3,
- Matthew Burge4,5,
- Benjamin Solomon3,6,
- Sze Ting Lee1,2,7,
- Kyle D. Holen8,
- Yumin Zhang9,
- Marika Ciprotti1,
- F.T. Lee1,
- Wijith Munasinghe8,
- JuDee Fischer8,
- Peter Ansell8,
- Gerard Fox8,
- Hao Xiong8,
- Edward B. Reilly8,
- Rod Humerickhouse8 and
- Andrew M. Scott1–37
- 1Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, Australia
- 2School of Cancer Medicine, La Trobe University, Melbourne, Australia
- 3Department of Medicine, University of Melbourne, Melbourne, Australia
- 4Royal Brisbane and Women's Hospital, Brisbane, Australia
- 5University of Queensland, Brisbane, Australia
- 6Peter MacCallum Cancer Centre, Melbourne, Australia
- 7Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia
- 8AbbVie, North Chicago, Illinois; and
- 9Sinotau Pharmaceutical Group, Beijing, China
- For correspondence or reprints contact: Hui K. Gan, Cancer Clinical Trial Center Austin Hospital, 145 Studley Rd., Heidelberg Victoria 3084, Australia. E-mail: hui.gan{at}onjcri.org.au
